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Abstract
While control banding has been identified as a suitable framework for the evaluation and the determination of
potential human health risks associated with exposure to nanomaterials (NMs), the approach currently lacks any
implementation that enjoys widespread support. Large inconsistencies in characterisation data, toxicological
measurements and exposure scenarios make it difficult to map and compare the risk associated with NMs based on
physicochemical data, concentration and exposure route. Here we demonstrate the use of Bayesian networks as a
reliable tool for NM risk estimation. This tool is tractable, accessible and scalable. Most importantly, it captures a
broad span of data types, from complete, high quality data sets through to data sets with missing data and/or
values with a relatively high spread of probability distribution. The tool is able to learn iteratively in order to further
refine forecasts as the quality of data available improves. We demonstrate how this risk measurement approach
works on NMs with varying degrees of risk potential, namely, carbon nanotubes, silver and titanium dioxide.
The results afford even non-experts an accurate picture of the occupational risk probabilities associated with these
NMs and, in doing so, demonstrated how NM risk can be evaluated into a tractable, quantitative risk comparator.
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Background
Control banding has been identified [1, 2] as a suitable
framework in which concerned stakeholders can evaluate
and determine the risks of nanomaterials (NMs) to human
health. Despite a broad consensus on the approach, there
are no significant implementations that have a widespread
support. This is because of known [3–5] inconsistencies in
characterisation, toxicological measurement and exposure
tests that are especially difficult to map using a risk tool.
The low volume of quality data relevant to NM risk
measurements presents further difficulties in the hazard
potential. Widespread recognition that the hazard poten-
tials of NMs can vary depending on chemistry, physico-
chemical characteristics, concentration and the mode and
time of exposure.
Several unique control banding (CB) solutions have been
identified [6] that utilize exposure and hazard banding to
evaluate occupational risk for nanomaterials. Each CB tool
offers alternative methodologies in order to estimate the
exposure potential and hazard, and hence classify the pre-
vailing risk within a ranking matrix. For example, NanoSafer
[7] combines a hazard evaluation derived from data
provided by technical information sheets, with an exposure
assessment determined by the occupational setting and
production rates to provide case-specific risk assessment of
manufactured nanomaterials. Similarly, the Nano-Evaluris
[8] CB solution assesses occupational inhalation risk pertain-
ing to nanopowders by combining hazard and exposure
band estimates with protective measures taken, process
emission evaluation and frequency of use. The physical form
(solid, liquid, powder or aerosol) of a manufactured nano-
material is used to determine the exposure/emission poten-
tial within the French agency for food, environmental, and
occupational health and safety (ANSES) [9] CB framework,
with the hazard band allocated according to the classifica-
tion of the bulk or analogous material according to the clas-
sification, labelling and packaging (CLP) regulation. While
CB tools are effective in classifying risk and establishing risk
management protocols 6, current applications have been
criticised regarding their inability to produce transparent or
easily communicable risk forecasts. Alternative frameworks
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employ multi criteria decision analysis (MCDA) and weight
of evidence (WoE) approaches, which enable expert judge-
ment and experimental data to be incorporated into the risk
assessment [10–12]. Indeed, for regulatory purposes,
MCDA-based tools may provide a more appropriate way to
address issues surrounding data uncertainty [13, 14]. How-
ever, the uncertainties underlying the use of expert opinion
to interpret the quality of experimental evidence or to estab-
lish weights for criterion in MCDA approaches may prove
to have a critical effect on the resultant assessment [11].
Finally, methodologies borrowing from the finance industry
[15], value of information and portfolio decision analysis can
also be employed with some success.
Bayesian networks (BNs) can be utilised to overcome
these limitations. BNs offer a reliable method for NM risk
estimation owing to their ability to capture data sets that
have a probability distribution of values or even missing
values. These omissions are commonly observed in toxico-
logical investigations related to NM risk characterisation
and assessment. Furthermore, BNs allow for the incorpor-
ation of expert opinion where data are lacking, and has the
functionality to refurbish these assessments as new experi-
mental data becomes available. The model can incorporate
NM-specific physicochemical characteristics, exposure
potential and hazard components relevant to NMs for all
exposure routes. In this article, we demonstrate the use
of BN in occupational settings (e.g. inhalation expos-
ure). The risk estimation is transparent and can be
used to prioritize further testing to increase accuracy.
More detailed NM characterisation, toxicological and
exposure information will produce a more accurate
risk estimation.
This framework enables proactive, iterative risk assess-
ment through its underlying Bayesian interpretation of
probability. Probability is subjective representing a degree
of belief that is updated as information or data is acquired.
In scarce data environments, new experimental data and
relevant data from literature to have a strong influence on
posterior probabilities as the process is updated via the
learning algorithm. This, we believe, is a strength over the
existing quantitative MCDA approaches [11] as the
uncertainty attributed to expert opinion diminishes as
additional experimental data are acquired. The margin of
exposure (or MOE) of a NM is the ratio of its no-
observed-adverse-effect level (NOAEL) to its predicted
dose. Within a BN, the MoE can then be mapped to a
control banding framework that affords even non-experts
an accurate picture of the risk profile associated with a
particular NM. Furthermore, the value of the risk forecast
is easily translated into a decision-making framework by
applying the US Environmental Protection Agency
(USEPA)-defined [16] inflection point of 1 (or 100% in
percentage terms) to determine whether a specific NM
poses a hazard to human health.
Methods
We apply our methodology to NMs made from silver (Ag),
titanium dioxide (TiO2) and carbon nanotubes (CNTs) and
focus on occupational exposure. For all three NMs, we
source data from the US National Institute for Occupa-
tional Safety and Health (NIOSH) exposure recommenda-
tion reports [17–19] and EU funded research consortia
[20–22] and then map the estimated risk to a control band-
ing solution using our model. To test the validity of our
approach, we run the model using a sample set of data
from a European research consortium database [23].
BNs are a class of probabilistic models originating from
the Bayesian statistics and decision theory combined with
graph theory [24, 25], which are able to model dependen-
cies between variables. They were developed as a probabil-
istic structure in 1921 for the analysis of crop failure [26]
and re-invented by many researchers under numerous
pseudo-names such as causal network, belief network and
influence diagram [27]. Modern applications of BNs are
used in the fields of medicine [28], information technology
and engineering [29], food fraud prediction [30] and envir-
onmental and human health risk assessment [31–36].
BNs offer an adaptive risk evaluation framework on two
separate levels. First, the model structure and parameteri-
zation can be refined as contemporary research grows and
improves the underlying assumptions used in the prelimin-
ary model formulations. Second, BNs are easily updatable
as new scientific data becomes available by means of
learning and updating model parameters and probability
distributions via Bayes’ theorem [37]. The ability to incorp-
orate a variety of traditional (i.e. experimental data) and
non-traditional knowledge bases such as expert judgement,
mechanistic or physical relationships and simulated data
into the parameterization process of a BN appeals to the
task of modelling complex systems in data-scarce environ-
ments, such as the NM risk assessment arena [38]. Using
BNs, a generalised risk assessment model (Fig. 1) can be
followed for the purpose of risk characterization of poten-
tially hazardous substances and then applied to a control
banding framework.
The transferability of the BN modelling framework to
the NM risk assessment paradigm such as control band-
ing is characterised by its mathematical flexibility in
terms of probability elicitation (mechanical, empirical or
expert judgement), its ability to adapt to new informa-
tion and its capacity to produce probabilistic forecasts in
low, and often missing data environments. Any variable
(node) in the graphical structure may have any number
of parents, including no parents. However, by increasing
the number of parents with multiple states conditionally
linked to a specific node, the number of conditional
probabilities or parameters, to be estimated grows expo-
nentially. While this may pose an issue as the structure
grows in complexity, there are strategies to approximate
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the conditional probability tables which have proven
adequate for these instances in the form of noisy
probability distributions [39]. For example, there is a
widespread uncertainty in the identification of hazard, or
more precisely, in determining the lowest threshold for
hazard identification. In applying BN, we resort to expert
elicitation from both primary (SANOWORK http://cor-
dis.europa.eu/project/rcn/102461_en.html) and second-
ary (NIOSH) data to ascertain input parameters and the
influence thereof on predecessors and successors in the
causal network leading to risk characterisation. Expert
interpretations in terms of the potential for human
health risk [40] are then incorporated in a BN where the
uncertainty of risk-associated variables are described as
probability distributions [41].
In line with Bergamaschi et al. (2015) [42], the following
NM characteristics were selected as model parameters
that contribute to hazard: size, surface area, chemical
reactivity, surface charge, solubility and morphology.
These were selected following an appraised of the litera-
ture and selected based on their influence in the particle’s
toxicological profile. They [ibid] also detail the hazard or
effect consequence of each physicochemical characteristic.
We also categorize NMs as carcinogenic, mutagenic or
toxic for reproduction (CMR) [43]. The choice of physico-
chemical characteristics is based on extant literature but
of course there is no clear consensus within that literature
set. BNs, however, can be configured to accommodate
diverse user opinions on specific hazard impacts and
multiple other parameters although a consensus or default
assumption would make the prediction better.
For toxicants, a threshold exposure level can be derived,
below which it is assumed there is no statistically significant
adverse effect to human health. As a point of departure for
this, the no-observed-adverse-effect level (NOAEL) is usu-
ally derived in animal studies, then a safety or uncertainty
factor is applied (usually 100) to determine the dose consid-
ered safe for humans. In the absence of an experimentally
determined NOAEL, the quantity lowest-observed-adverse-
effect level (LOAEL) can be used as is the lowest dose tested
for a potential hazard. Alternatively, the benchmark dose
(BMD) [44, 45] method can be employed. We will use the
term occupational exposure limit (OEL) term as the upper
boundary on acceptable dose concentrations. NIOSH
periodically disseminate new scientific data relating to po-
tential occupational hazard from NMs (such as scientifically
derived NOAELs) and recommend occupational exposure
limits. There is, however, considerable disparity between
recommended OELs proposed by NIOSH, regulatory bodies
and academia. For example, current recommendations relat-
ing to CNTs range from 1 to 50 μm/m3 [17]. NMs’ human
occupational exposure potential is the probabilistic measure
of the propensity of the NM to enter the human body by
inhalation, ingestion or dermal pathways. For NMs, there
remains substantial ambiguity as regards the most relevant
exposure metric [4, 46–48]. This remains a challenge as only
a limited number of the nanomaterial parameters can be
determined reliably [4, 49]. We have used the expectation–
maximization (EM) learning algorithm in the BN to refine
the conditional probabilities in parameterization of the risk
assessment model using literature and experimental data.
We also demonstrate the learning ability of BNs to handle
risk data for CNT, Ag and TiO2 NMs as new scientific data
and/or expert knowledge becomes available. For example,
recommended OELs and occupational exposure data
provided in the NIOSH reports [17–19] are used to learn
the parameters within their corresponding nodes.
Within each node of the BN, we incorporate experi-
ence to measure the confidence attributed to the condi-
tional probabilities inferred via specialist data sources.
Any initial subjective choices of data can be refined to
reduce bias using more data from diverse sources. This
learning-through-experience feature allows us to con-
tinually define the sensitivity of the models’ parameters
to new information. The idea is that if a given expert (or
a group of experts) has a low confidence in their initial
data choice, new information would make a considerable
impact on this initial estimate and support the subse-
quent data with better confidence and experience. Once
the model is updated with case data, the experience
value corresponding to each state within a node coin-
cides with the number of cases that have been observed.
Results
Figure 2 summarises the 12 key physicochemical character-
istics identified by us as influential variables for defining
the potential exposure and toxicity of pristine CNT; the
figures for Ag and TiO2 are available as supplementary
Fig. 1 The 4-step top-down human health risk assessment framework
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Fig. 2 (See legend on next page.)
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data. This includes the discretized states and causal links
between these states. The presence of a surface coating is
also included as it is experimentally proven to induce
changes in the state of specific structural determinants of
hazard when compared to an uncoated, pristine state [42].
The degree of agglomeration/aggregation and dispersibility
are additional characteristics known to be important fac-
tors in the causal chain of assigning NMs risk potential
[40]. Conditional relationships, signified by directed arrows
starting from the influential parent nodes and ending at
the child nodes, are determined by expert opinions derived
from relevant contemporary literature [17–22] and SANO-
WORK [32, 40]. For example, the directed arrow from De-
gree of Aggregation to Particle Size implies that the rate at
which NMs attach to other NMs of the same type has a
direct impact on the NM’s size distribution. Marginal vari-
ables (i.e. the nodes with no network parents, (Coating, pH
and Contamination)) are assumed to be represented by
uniform distributions for unbiased parameterization when
adequate knowledge is lacking [32].
The exposure potential component is conditionally linked
to the physicochemical characteristics component via par-
ent nodes dispersibility and solubility (Fig. 2). The relation-
ship is inferred from the expert opinion (NIOSH reports)
used in developing the influence diagram [40]. The NMs
Concentration in Air variable is discretized into intervals
that gradually increase in range as the value of the variable
increases to offer increased granularity at the left tail of the
distribution where the likelihood of occurrence is greater.
Both exposure potential and dose-response assessments
are incorporated in the BNs to generate a quantitative
forecast of risk with parameterization (Fig. 2). Two dis-
tinct dose-response assessment models have been tested
for carcinogenic (linear model) and non-carcinogenic
(threshold model) toxicants [41, 50] via the OEL and are
directly parameterized by its parent node CMR. Integrat-
ing both of these dose-response assessment ideologies into
the Bayesian framework enables us to create a risk assess-
ment model that accounts for both inter-batch and experi-
mental inconsistencies in the relevant data, and also
captures the uncertainty surrounding the toxicity potential
of many NMs [51].
We define the margin of exposure as the hazard quo-
tient (HQ), quantified by dividing the exposure potential
of NMs concentration in air by the threshold value OEL.
The resultant value represents the initial deterministic risk
forecast generated by the BN risk assessment model. If the
forecasted exposure level is greater than the threshold
dose, i.e. HQ > 100%, there exists potential risks of adverse
human health implications for the particular NM. The
HQ can be refined through a robust learning process in
BN and offers a coherent and quantifiable human health
risk assessment. It consolidates exposure, hazard and
dose-response assessments into a single risk forecast.
Discussion
For CNTs, Ag and TiO2 NMs, we created a database of
information based on the NIOSH and EU research reports
on each material [17–22]. Each NIOSH report referenced
numerous publications from which the secondary data
was sourced. We created 46 rows of CNT data, 39 rows of
Ag data and 55 rows of TiO2 data. All references and data
are available as supplementary data. The datasets con-
tained high levels of missing data as is typical of data from
different sources. The results are plotted in a heat map
(Fig. 3) and show the estimated risk of each material using
the BN approach.
At a glance, we can see from Fig. 3 that CNTs, Ag and
TiO2 NMs exhibit increasing levels of risk as we would
anticipate. The heat map can be superimposed onto a con-
trol banding solution that could exhibit hazard and expos-
ure rows and columns, this may be particularly suitable for
labelling purposes or a decision-making process. The
relatively wide confidence bands are indicative of the
amount and quality of the available data. Clearly, more data
sources with less missing data will strengthen the degree of
certainty.
To further validate our approach, we then applied the
same BN approach to a primary data source, the SANO-
WORK database. This is, in effect, an out-of-sample test to
check the accuracy of the learned system. We include these
results in Fig. 3. The results from the secondary and pri-
mary data are consistent with expectations with the out-of-
sample results falling within the 90% confidence interval.
Conclusions
Our BN approach has empirically found a solution to
measuring the risk of NMs which has been a particularly
vexing problem across the lifecycle of manufactured NMs.
In this article, we have used secondary data from research
articles cited by the NIOSH occupational exposure reports
and EU research consortia to estimate the risk of CNTs, Ag
and TiO2 and to map these results to a control banding
solution that is intuitive and accessible to a wide variety of
(See figure on previous page.)
Fig. 2 Graphical structure and parameterization for the physicochemical characteristics component of the CNT Bayesian network. Each node
displays the variable name (top), possible states (left) and the % probability of being in a specific state inferred from the conditional probability
table for the node with associated bar chart (centre, right). Directed arrows symbolise the conditional relationship between parent and child nodes.
Continuous variables display the centre of the probability distribution and its variance. The parameter data was sourced from the National
Institute for Occupational Safety and Health (NIOSH) and the EU Project, SANOWORK
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interested parties. The approach identified here is applied
with a particular bias on human health factors, particularly
in an occupational setting but there is no reason not to ex-
tend the approach to include a more general human health
and environmental risks. To be sure, a greater discussion
surrounding the input parameters and causal relationships
is inevitable, but if a consensus can be found then, by defin-
ition, we have a template for a database design that can be
used by experts in categorization, exposure assessment and
toxicology. Where more data from research and industry
published to this template, then the accuracy of risk meas-
urement would quickly increase.
Our approach is a quantitative solution that offers a more
objective approach than subjective, semi-quantitative
methods. In addition to offering an alternative in the
continuum of risk modelling approaches (e.g. mechanistic,
statistical, Bayesian and decision-analytic [13]) for NM risk,
our BN tool could also be used in conjunction with a
weight of evidence [10] approach and/or multi criteria deci-
sion analysis methodologies [52]. With a quantitative result,
users will be in a position to reduce exposure pathways or
ameliorate hazard profiles by engineering the NM through
coating (say). This BN approach is a particularly powerful
approach when combined with material modelling and
safety by design paradigms. By modelling the physicochem-
ical properties of proposed NMs, an estimate of the poten-
tial risk increase/reduction of the resultant material can be
derived. It may also be developed as a tool to promote
occupational safety standards and extended to examine all
NM lifecycle risks. With this said, the strength of BN ap-
proach derives from a consensus view on the variables and
a resultant standardised database. The corollary of disperse,
heterogeneous datasets with a wide variability in material
properties will limit the potential of BN techniques. There-
fore, national and supranational efforts to standardise nano-
material information sets are highly desirable.
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